This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...
The Basketball Hall of Famer had surgery to remove cancerous lymph nodes from his neck. He was previously treated for ...